Clinical trial · Interventional
Study of MR-based IGRT for Prostate Cancer
Single-arm Phase II Study of MR(Magnetic Resonance Imaging)-Based Image-guided Radiotherapy for Prostate Cancer
NCT02724670CI-TRIAL-00040817M-baseProrecruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
MR (Magnetic Resonance Imaging) - based IGRT (image-guided radiotherapy) for patients with prostate carcinoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| IGRT | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Radiation
- description
- IGRT 5x 2Gy/week, total dose: 78 Gy
- interventionNames
- Radiation: IGRT
Primary outcomes (1)
- measure
- G2+gastrointestinal and genitourinary toxicity at 2 years
- timeFrame
- Total trial treatment duration: 4 years, Duration for individual patient:Study treatment 9 months, Follow-up: 2 years for primary endpoint
- description
- Number of participants with G2+-treatment-related genitournary and gastrointestinal adverse events assessed by CTCAE v4.0 and RTOG at 2 years
Secondary outcomes (1)
- measure
- Long-term GU-GI toxicity
- timeFrame
- 10 years after treatment
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * histologically proven prostate cancer * indication for curative treatment * ECOG performance scale 0-2 * Informed consent Exclusion Criteria: * contraindications for curative treatment * age\<18year * previous pelvic radiotherapy or prostatic treatment like TURP (transurethral resection of prostate), HIFU (high intensity focused ultrasound) * serious comorbidity leading to inability for IGRT (image-guided radiotherapy) * contraindications for MRI (Magnetic Resonance Imaging)
References
Publications (0)
Data not yet available
No reference posted for this study.